Incanthera
Goal Group
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
    • Our History
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
    • Financial calendar
    • Shareholder information
    • Investor and Advisor contacts
    • AQSE Growth Market Rule 4.14
    • Corporate Governance
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us
  • Sustainability
Share price INC GBp
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
      • Board of Directors
      • Senior Management
      • Advisors and Founders
    • Our History
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
      • Share price chart
      • Detailed share price
    • Financial calendar
    • Shareholder information
      • Shareholder Information
      • AGM
      • GM
      • Analyst coverage
    • Investor and Advisor contacts
    • AQSE Growth Market Rule 4.14
    • Corporate Governance
      • Corporate Governance Report
      • QCA Corporate Governance Principles
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us
  • Sustainability

News

  • Home
  • News & media
  • News
  • News
  • Press Coverage
  • Scientific Publications

Latest from Incanthera

News

  • 2025
  • 2024
  • 2023
  • Archive
May 22nd, 2025 Commercial Update
April 1st, 2025 Extension of Warrants and Debt Conversion and Issue of Equity
March 28th, 2025 Commercial Update
March 25th, 2025 Successful Resolution of Allegations of Patent Infringement
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
Sign up for email alerts Register your email

This website uses cookies. By continuing to access the site you are agreeing to their use. Learn more about cookies.

  • © 2025 Incanthera plc

  • Sitemap
  • Contact Us
  • Privacy Policy

By  emperor